Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q1 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.